Author:
Bangalee Varsha,Suleman Fatima
Funder
Fogarty International Centre
National Institutes of Health
Office of Strategic Coordination
Office of the Director
Office of AIDS Research
National Institute of Mental Health
University Capacity Development
University of KwaZulu-Natal
Subject
Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Economics, Econometrics and Finance (miscellaneous)
Reference19 articles.
1. Evaluating the pricing interventions in the private sector of the South African pharmaceutical distribution chain;Bangalee,2017
2. Policies to control prices of medicines: does the South African experience have lessons for other African countries?;Ngozwana,2016
3. Potential cost savings from generic medicines—protecting the prescribed minimum benefits;Nicolosi;S Afr Fam Pract,2009
4. Has the increase in the availability of generic drugs lowered the price of cardiovascular drugs in South Africa?;Bangalee;Health SA Gesondheid,2016
5. Originator and generic medicine: pricing and market share;Van der Merwe Smit;Int J Pharm Healthcare Marketing,2013
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献